J.P. Morgan Turns All Eyes toward Biotech
BioWorld’s Peter Winter reports that the mood is upbeat at today’s kickoff of the 33rd annual J.P. Morgan Healthcare Conference in San Francisco (check out the story here, subscription required)....
View ArticleDr. Petra Kaufmann Video Interview: Clinical and Translational Science Awards...
Petra Kaufmann, MD, MSc, Director of the Division of Clinical Innovation at the National Institutes of Health, recently joined us in the BIO Buzz Center to discuss streamlining clinical trials through...
View ArticleClik here to view.
Good Public Policy Key to Stable Biotech Investment Climate
It is an important and exciting time for the biotechnology industry. Science is galloping forward and investment continues to flow to promising programs across the country. The one area that can slow...
View ArticleClik here to view.
BIO CEO & Investor Conference Succeeds in Bringing Innovators to Investors...
The 19th Annual BIO CEO & Investor Conference came to a close February 14, having drawn more than 1,225 attendees including nearly 500 investors. During a busy two days, over 2,650 partnering...
View ArticleClik here to view.
High Caliber Investors Flock to BIO CEO & Investor Conference
Today the 20th BIO CEO & Investor Conference opens in New York City amid a decidedly upbeat investment climate for the biotechnology sector. Last year we saw a 54% increase in investment for...
View ArticleClik here to view.
2018 BIO Investor Forum Wraps Up
As the stock market continued its volatile swings this week, investors at the BIO Investor Forum—which wrapped up today in San Francisco—seemed to take it all in stride and remain focused on the...
View ArticleClik here to view.
#BIOWC19 Day 2 Wrap-Up: Innovating for a Sustainable Future
Day two of BIO’s 2019 World Congress started bright and early with hundreds of global biotechnology leaders—including company executives, researchers, investors, and government officials—arriving in...
View Article